According to the current analysis of Reports and Data, the global Sacral neuromodulation market was valued at USD 2,432.9 Million in 2020 and is expected to reach USD 3,498.2 Million by year 2028, at a CAGR of 4.94 %.
According to the current analysis of Reports and Data, the global Sacral neuromodulation market was valued at USD 2,432.9 Million in 2020 and is expected to reach USD 3,498.2 Million by year 2028, at a CAGR of 4.94 %. The study covers in-depth analysis of Sacral Neuromodulation and the treatments to cure it. Overactive bladder symptoms of urgency, frequency and incontinency is at present affecting a significant amount of population, especially when age increases. Sacral Neuromodulation (also known as sacral nerve stimulation) has been one of the popular and effective treatment options to cure overactive bladder and bowel problems for more than last 2 decades. The main purpose of the Sacral Neuro modulation is to improve the coordination between bladder/bowel and our brain. One of the proven treatments include sacral neuromodulation via the interstim system. The procedure is divided into two main stages which include basic evaluation and advanced evaluation. In both the evaluations a portable, external stimulator which generates stimulations is delivered through a lead.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1487
Number of companies are engaged in launching new devices for SNM with minimal pain and side effects. For instance, launch of smaller implantable neurostimulator Interstim II manufactured by Medtronic has helped to improve patient ‘s comfort and has also made the procedure of the physicians easier and shorter. The patient has to wear the stimulator throughout the two evaluations. The basic evaluation includes simple, in-office procedure whereas the advanced evaluation is performed in hospitals, clinics, surgical centers. The global market is propelled by number of factors such as increasing geriatric, rise in the neurological diseases and failure of conventional treatments (exercise, changes in lifestyle, diet) to cure SNM. However adverse effects and complications in some of the SNM treatments are the major hindrances for market growth in 2019-2028.
Further key findings from the report suggest
-
- North America is the largest revenue generating region in the global Sacral neuromodulation market. It holds 35.5% of the total market share owing to the technological advancements and rising awareness about SNM. Followed by that, Europe accounts for 31.2% of the total market share.
- Implantable SNM devices in comparison to external SNM devices is a more popular option on a global level. It holds 62.5% of the total market share whereas External SNM device holds 33.3% of the total market share.
- Medtronic is the dominating player in manufacturing SNM instruments, devices in the global market. In 2015, Medtronic had net sales worth USD 3.8 billion in neuromodulation. Gastrointestinal and urological devices were the prime factors for the rapid growth of Medtronic.
- Axonics Modulation Technologies acquired investments in SNM worth 38.5 million to extensively study about OAB implants in North America and Europe and is expected to surpass medical device giant Medtronic’s popular and successful Interstim system in the coming future. The Axonics SNM system is compatible, given few precautions, with 1.5 Tesla and 3 Tesla MRI scanners. It is the only SNM system clearing in Europe with such labelling. Axonics ‘s SNM device is rechargeable and also has a guaranteed lifetime up to 15 years (3 times longer than Medtronic’s Interstim). It is also 60% smaller than Interstim device.
- Welkin Health, a privately-held patient relationship management software company has recently announced that it will be collaborating with Axonics Modulation Technologies in finding new solutions for SNM.
- With only a handful of players in the market, there are tremendous opportunities for companies like Axonics to enter in the market.
- Revenue from the sale of SNM devices is estimated to be rise around USD 600 million annually with nearly 30,000 devices implanted in patients in 2014 alone.
- Revenue for this market is estimates to grow to over USD1 billion by the end of 2019.
- According to a US-based study, overactive bladder (OAB) symptoms are prevalent in 17% males and 17.9% in female population in US.
- In case of Europe, 16% men and 17.8% women above 40 years of age were estimated to have OAB symptoms in the coming years.
- Associated side effects related to SNM treatments and lack of awareness about Sacral neuromodulation is likely to hinder the market growth during the forecast period.
The ongoing pandemic is significantly changing the dynamics of the pharma and healthcare sector. Various countries are facing challenges such as shortage of medicines, vaccines, healthcare devices in hospitals. This is expected to open lucrative growth opportunities for market players in the coming years.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
Cyberonics, St Jude Medicals, Boston Scientific, Medtronic.
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/sacral-neuromodulation-market
Sacral Neuromodulation Market Segmentation:
Product (Revenue, USD Million; 2020–2028)
- Implantable SNM devices
- External SNM devices
Application (Revenue, USD Million; 2020–2028)
- Urinary incontinence
- Urge incontinence
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1487
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports By Reports and Data:
Transfer Bench Market, By Product (Retractable, Ordinary), By Application (Residential, Commercial, Others), and Region Forecast to 2028 Download PDF Brochure
Biosurgery Market, By Product Type (Bone-graft Substitutes, Soft-tissue Attachments, Hemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers, Staple Line Reinforcement Agents), By End-use, By Application, and By Region Forecast to 2028 Download PDF Brochure
Orthobiologics Market By Product Type (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics , Bone Morphogenic Protein, Allografts, and Plasma-Rich Protein), By End Use, By Application, and Region, Forecast to 2028 Download PDF Brochure
Medical Device Cleaning Market, By Process (Disinfection, Automatic Cleaning, Manual Cleaning, Presoaking/Precleaning), By Application, By End-Use, and By Region Forecast to 2028 Download PDF Brochure
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports